MedPath

SINPHAR PHARMACEUTICAL CO., LTD.

SINPHAR PHARMACEUTICAL CO., LTD. logo
🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

Phase 4
Completed
Conditions
Stage-â…¡ Colorectal Cancer
Interventions
Drug: Orectalip
First Posted Date
2014-11-06
Last Posted Date
2014-11-06
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
20
Registration Number
NCT02284529
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

Phase II Study of STA-2 in Patients With Chronic Stable Angina

Phase 2
Completed
Conditions
Chronic Stable Angina
Interventions
Drug: Placebo
First Posted Date
2011-12-02
Last Posted Date
2011-12-06
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
79
Registration Number
NCT01484912
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

🇨🇳

Chi Mei Medical Center, Tainan, Taiwan

Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

Phase 2
Completed
Conditions
Vascular Dementia
Interventions
Drug: Ergoloid Mesylates tablet
First Posted Date
2011-11-21
Last Posted Date
2011-11-21
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
240
Registration Number
NCT01475578
Locations
🇨🇳

Hospital (Traditional Chinese Medicine) Affiliated to Luzhou Medical College, Luzhou, China

🇨🇳

Affiliated Hospital of Chengdu University of Traditional Chinese Medicines, China, Chengdu, China

🇨🇳

Affiliated Hospital of Shaanxi Academy of Traditional Chinese Medicine,, Shaanxi, China

and more 2 locations

Study of STA-1 as an Add-on Treatment to Donepezil

Phase 2
Conditions
Alzheimer Disease
Interventions
Drug: Donepezil,
Drug: placebo
First Posted Date
2010-12-07
Last Posted Date
2014-08-20
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
136
Registration Number
NCT01255046
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

Phase IIb Study of STA-2 in Patients With Chronic Stable Angina

Phase 2
Completed
Conditions
Chronic Stable Angina
Interventions
Drug: green tea polyphenols (STA-2)
First Posted Date
2010-11-11
Last Posted Date
2014-08-27
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
186
Registration Number
NCT01239511
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

🇨🇳

Chi Mei Medical Center, Tainan, Taiwan

🇨🇳

Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath